GHO Capital Sells VISUfarma to Lupin

London, Mumbai, 29 September, 2025: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is delighted to announce the sale of VISUfarma, a specialty pharmaceutical company focused on ophthalmology, to global pharma major Lupin Limited (Lupin).VISUfarma was created by GHO Capital in 2016 by combining the founder-owned Italian VISUfarma with the European commercial operations of Nicox S.A. Since its initial investm